Tourmaline Short Long Term Debt Total vs Short Term Investments Analysis

TRML Stock

26.04 0.38 1.48%

Tourmaline Bio financial indicator trend analysis is much more than just breaking down Tourmaline Bio prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Tourmaline Bio is a good investment. Please check the relationship between Tourmaline Bio Short Long Term Debt Total and its Short Term Investments accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tourmaline Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For more information on how to buy Tourmaline Stock please use our How to buy in Tourmaline Stock guide.

Short Long Term Debt Total vs Short Term Investments

Short Long Term Debt Total vs Short Term Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Tourmaline Bio Short Long Term Debt Total account and Short Term Investments. At this time, the significance of the direction appears to have pay attention.

The correlation between Tourmaline Bio's Short Long Term Debt Total and Short Term Investments is -0.84. Overlapping area represents the amount of variation of Short Long Term Debt Total that can explain the historical movement of Short Term Investments in the same time period over historical financial statements of Tourmaline Bio, assuming nothing else is changed. The correlation between historical values of Tourmaline Bio's Short Long Term Debt Total and Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Long Term Debt Total of Tourmaline Bio are associated (or correlated) with its Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Term Investments has no effect on the direction of Short Long Term Debt Total i.e., Tourmaline Bio's Short Long Term Debt Total and Short Term Investments go up and down completely randomly.

Correlation Coefficient

-0.84

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Short Long Term Debt Total

Short Term Investments

Short Term Investments is an item under the current assets section of Tourmaline Bio balance sheet. It contains any investments Tourmaline Bio undertook that will expire in less than one year. These accounts contain financial instruments such as stocks or bonds that Tourmaline Bio can easily liquidate in the marketplace.

Most indicators from Tourmaline Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Tourmaline Bio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tourmaline Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For more information on how to buy Tourmaline Stock please use our How to buy in Tourmaline Stock guide.At this time, Tourmaline Bio's Selling General Administrative is quite stable compared to the past year. Enterprise Value Over EBITDA is expected to rise to 0.37 this year, although the value of Issuance Of Capital Stock will most likely fall to about 100.3 M.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	904.0	19.7M	45.4M	23.2M
Cost Of Revenue	623K	6K	33K	31.4K

Total Operating Expenses Cost Of Revenue

Tourmaline Bio fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Accounts Payable	Other Assets	Short Term Investments	Short Long Term Debt Total	Current Deferred Revenue	Net Invested Capital	Short Long Term Debt	Net Working Capital
Total Assets		0.53	0.79	1.0	-0.35	-0.84	-0.98	0.85	-0.04	0.83	1.0	-0.19	-0.22	0.81	0.88	0.04	1.0	-0.51	0.47	0.27	-0.35	0.47	-0.2	0.89	-0.84	0.87
Other Current Liab	0.53		0.89	0.56	-0.65	-0.54	-0.6	0.53	-0.61	0.21	0.53	-0.73	-0.48	0.32	0.33	-0.35	0.53	-0.38	0.99	0.74	-0.21	-0.1	-0.46	0.35	-0.19	0.31
Total Current Liabilities	0.79	0.89		0.79	-0.56	-0.71	-0.85	0.69	-0.4	0.53	0.79	-0.48	-0.29	0.55	0.62	-0.11	0.79	-0.56	0.87	0.57	-0.39	0.25	-0.27	0.62	-0.44	0.6
Total Stockholder Equity	1.0	0.56	0.79		-0.31	-0.85	-0.96	0.85	-0.02	0.81	0.99	-0.28	-0.31	0.83	0.87	-0.06	1.0	-0.46	0.5	0.25	-0.27	0.39	-0.3	0.88	-0.82	0.86
Property Plant And Equipment Net	-0.35	-0.65	-0.56	-0.31		0.48	0.52	-0.52	0.93	-0.31	-0.34	0.07	-0.17	-0.17	-0.34	-0.33	-0.34	0.38	-0.68	-0.93	0.76	-0.4	-0.21	-0.32	0.32	-0.34
Net Debt	-0.84	-0.54	-0.71	-0.85	0.48		0.85	-1.0	0.17	-0.9	-0.84	0.12	0.29	-0.94	-0.95	0.04	-0.84	0.08	-0.54	-0.28	0.36	-0.49	0.24	-0.96	0.89	-0.95
Retained Earnings	-0.98	-0.6	-0.85	-0.96	0.52	0.85		-0.86	0.23	-0.83	-0.97	0.14	0.09	-0.75	-0.87	-0.17	-0.97	0.59	-0.56	-0.44	0.53	-0.56	0.06	-0.86	0.8	-0.86
Cash	0.85	0.53	0.69	0.85	-0.52	-1.0	-0.86		-0.19	0.9	0.84	-0.11	-0.27	0.93	0.95	-0.01	0.85	-0.11	0.53	0.31	-0.38	0.51	-0.22	0.96	-0.91	0.95
Non Current Assets Total	-0.04	-0.61	-0.4	-0.02	0.93	0.17	0.23	-0.19		0.05	-0.04	0.17	-0.17	0.17	0.02	-0.24	-0.04	0.34	-0.65	-0.96	0.62	-0.13	-0.2	0.03	-0.03	0.02
Non Currrent Assets Other	0.83	0.21	0.53	0.81	-0.31	-0.9	-0.83	0.9	0.05		0.83	0.25	0.04	0.9	0.99	0.28	0.83	-0.19	0.2	0.05	-0.48	0.76	0.08	0.98	-0.94	0.99
Cash And Short Term Investments	1.0	0.53	0.79	0.99	-0.34	-0.84	-0.97	0.84	-0.04	0.83		-0.19	-0.21	0.81	0.88	0.04	1.0	-0.51	0.47	0.27	-0.35	0.47	-0.2	0.88	-0.83	0.87
Common Stock Shares Outstanding	-0.19	-0.73	-0.48	-0.28	0.07	0.12	0.14	-0.11	0.17	0.25	-0.19		0.86	-0.09	0.09	0.84	-0.19	0.02	-0.7	-0.3	-0.49	0.72	0.87	0.04	-0.15	0.12
Non Current Liabilities Total	-0.22	-0.48	-0.29	-0.31	-0.17	0.29	0.09	-0.27	-0.17	0.04	-0.21	0.86		-0.38	-0.11	0.96	-0.22	-0.37	-0.46	0.06	-0.7	0.68	1.0	-0.17	0.1	-0.08
Other Current Assets	0.81	0.32	0.55	0.83	-0.17	-0.94	-0.75	0.93	0.17	0.9	0.81	-0.09	-0.38		0.95	-0.15	0.82	0.07	0.31	-0.05	-0.12	0.41	-0.34	0.96	-0.9	0.94
Other Stockholder Equity	0.88	0.33	0.62	0.87	-0.34	-0.95	-0.87	0.95	0.02	0.99	0.88	0.09	-0.11	0.95		0.14	0.88	-0.17	0.32	0.11	-0.41	0.65	-0.07	1.0	-0.95	1.0
Total Liab	0.04	-0.35	-0.11	-0.06	-0.33	0.04	-0.17	-0.01	-0.24	0.28	0.04	0.84	0.96	-0.15	0.14		0.04	-0.47	-0.35	0.18	-0.83	0.82	0.97	0.08	-0.17	0.17
Total Current Assets	1.0	0.53	0.79	1.0	-0.34	-0.84	-0.97	0.85	-0.04	0.83	1.0	-0.19	-0.22	0.82	0.88	0.04		-0.51	0.47	0.27	-0.35	0.47	-0.2	0.89	-0.84	0.88
Common Stock	-0.51	-0.38	-0.56	-0.46	0.38	0.08	0.59	-0.11	0.34	-0.19	-0.51	0.02	-0.37	0.07	-0.17	-0.47	-0.51		-0.3	-0.51	0.59	-0.39	-0.35	-0.14	0.12	-0.18
Accounts Payable	0.47	0.99	0.87	0.5	-0.68	-0.54	-0.56	0.53	-0.65	0.2	0.47	-0.7	-0.46	0.31	0.32	-0.35	0.47	-0.3		0.75	-0.23	-0.09	-0.44	0.33	-0.17	0.3
Other Assets	0.27	0.74	0.57	0.25	-0.93	-0.28	-0.44	0.31	-0.96	0.05	0.27	-0.3	0.06	-0.05	0.11	0.18	0.27	-0.51	0.75		-0.6	0.13	0.08	0.1	-0.1	0.11
Short Term Investments	-0.35	-0.21	-0.39	-0.27	0.76	0.36	0.53	-0.38	0.62	-0.48	-0.35	-0.49	-0.7	-0.12	-0.41	-0.83	-0.35	0.59	-0.23	-0.6		-0.84	-0.73	-0.36	0.36	-0.43
Short Long Term Debt Total	0.47	-0.1	0.25	0.39	-0.4	-0.49	-0.56	0.51	-0.13	0.76	0.47	0.72	0.68	0.41	0.65	0.82	0.47	-0.39	-0.09	0.13	-0.84		0.71	0.6	-0.61	0.68
Current Deferred Revenue	-0.2	-0.46	-0.27	-0.3	-0.21	0.24	0.06	-0.22	-0.2	0.08	-0.2	0.87	1.0	-0.34	-0.07	0.97	-0.2	-0.35	-0.44	0.08	-0.73	0.71		-0.13	0.06	-0.04
Net Invested Capital	0.89	0.35	0.62	0.88	-0.32	-0.96	-0.86	0.96	0.03	0.98	0.88	0.04	-0.17	0.96	1.0	0.08	0.89	-0.14	0.33	0.1	-0.36	0.6	-0.13		-0.95	1.0
Short Long Term Debt	-0.84	-0.19	-0.44	-0.82	0.32	0.89	0.8	-0.91	-0.03	-0.94	-0.83	-0.15	0.1	-0.9	-0.95	-0.17	-0.84	0.12	-0.17	-0.1	0.36	-0.61	0.06	-0.95		-0.95
Net Working Capital	0.87	0.31	0.6	0.86	-0.34	-0.95	-0.86	0.95	0.02	0.99	0.87	0.12	-0.08	0.94	1.0	0.17	0.88	-0.18	0.3	0.11	-0.43	0.68	-0.04	1.0	-0.95

Click cells to compare fundamentals

Tourmaline Bio Account Relationship Matchups

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Tourmaline Bio is a strong investment it is important to analyze Tourmaline Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Tourmaline Bio's future performance. For an informed investment choice regarding Tourmaline Stock, refer to the following important reports:

How To Invest In Tourmaline

Details

Is Tourmaline Stock a good investment?

Details

What is Tourmaline Bio's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tourmaline Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For more information on how to buy Tourmaline Stock please use our How to buy in Tourmaline Stock guide.

You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tourmaline Bio. If investors know Tourmaline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tourmaline Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.49)

Return On Assets

(0.24)

Return On Equity

(0.32)

The market value of Tourmaline Bio is measured differently than its book value, which is the value of Tourmaline that is recorded on the company's balance sheet. Investors also form their own opinion of Tourmaline Bio's value that differs from its market value or its book value, called intrinsic value, which is Tourmaline Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tourmaline Bio's market value can be influenced by many factors that don't directly affect Tourmaline Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Tourmaline Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tourmaline Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tourmaline Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Tourmaline Short Long Term Debt Total vs Short Term Investments Analysis

Short Long Term Debt Total vs Short Term Investments

Short Long Term Debt Total vs Short Term Investments Correlation Analysis

Correlation Coefficient

Short Long Term Debt Total

Short Term Investments

Tourmaline Bio fundamental ratios Correlations

Tourmaline Bio Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Stockholder Equity
Total Current Assets	+ 1.0	Cash And Short Term Investments
Current Deferred Revenue	+ 1.0	Non Current Liabilities Total

Cash	- 1.0	Net Debt
Retained Earnings	- 0.98	Total Assets
Total Current Assets	- 0.97	Retained Earnings
Cash And Short Term Investments	- 0.97	Retained Earnings
Other Assets	- 0.96	Non Current Assets Total
Net Invested Capital	- 0.96	Net Debt